Xebio Holdings Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Xebio Holdings has been growing earnings at an average annual rate of 42.4%, while the Specialty Retail industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 2.5% per year. Xebio Holdings's return on equity is 2.8%, and it has net margins of 1.4%.
Belangrijke informatie
42.4%
Groei van de winst
42.4%
Groei van de winst per aandeel
| Specialty Retail Groei van de industrie | 11.2% |
| Inkomstengroei | 2.5% |
| Rendement op eigen vermogen | 2.8% |
| Nettomarge | 1.4% |
| Volgende winstupdate | 08 Nov 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Xebio Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 245,309 | 3,390 | 84,947 | 0 |
| 31 Mar 24 | 242,433 | 2,592 | 84,292 | 0 |
| 31 Dec 23 | 241,075 | 3,423 | 82,908 | 0 |
| 30 Sep 23 | 241,317 | 4,272 | 81,455 | 0 |
| 30 Jun 23 | 240,096 | 4,207 | 81,271 | 0 |
| 31 Mar 23 | 239,293 | 5,397 | 80,006 | 0 |
| 31 Dec 22 | 236,601 | 4,460 | 80,543 | 0 |
| 30 Sep 22 | 234,164 | 5,370 | 79,554 | 0 |
| 30 Jun 22 | 228,772 | 4,933 | 78,951 | 0 |
| 31 Mar 22 | 223,282 | 3,836 | 78,583 | 0 |
| 31 Dec 21 | 219,821 | 4,120 | 76,818 | 0 |
| 30 Sep 21 | 218,632 | 1,888 | 76,309 | 0 |
| 30 Jun 21 | 217,555 | 2,969 | 74,919 | 0 |
| 31 Mar 21 | 202,438 | 412 | 72,540 | 0 |
| 31 Dec 20 | 201,026 | -359 | 72,946 | 0 |
| 30 Sep 20 | 198,759 | -925 | 74,582 | 0 |
| 30 Jun 20 | 205,372 | -1,567 | 76,472 | 0 |
| 31 Mar 20 | 225,312 | 408 | 80,083 | 0 |
| 31 Dec 19 | 231,276 | -118 | 80,807 | 0 |
| 30 Sep 19 | 232,697 | -80 | 79,628 | 0 |
| 30 Jun 19 | 231,087 | 485 | 79,354 | 0 |
| 31 Mar 19 | 231,629 | 1,884 | 78,508 | 0 |
| 31 Dec 18 | 232,282 | 2,258 | 78,272 | 0 |
| 30 Sep 18 | 234,243 | 3,958 | 78,237 | 0 |
| 30 Jun 18 | 235,222 | 4,578 | 77,954 | 0 |
| 31 Mar 18 | 234,595 | 4,249 | 77,883 | 0 |
| 31 Dec 17 | 231,511 | 5,347 | 76,890 | 0 |
| 30 Sep 17 | 227,157 | 4,259 | 76,917 | 0 |
| 30 Jun 17 | 225,408 | 3,450 | 76,626 | 0 |
| 31 Mar 17 | 223,353 | 2,991 | 76,626 | 0 |
| 31 Dec 16 | 222,832 | 2,052 | 75,413 | 0 |
| 30 Sep 16 | 223,547 | 1,503 | 75,522 | 0 |
| 30 Jun 16 | 222,069 | 1,681 | 74,891 | 0 |
| 31 Mar 16 | 221,391 | 2,118 | 74,200 | 0 |
| 31 Dec 15 | 220,067 | 2,391 | 73,233 | 0 |
| 30 Sep 15 | 218,242 | 2,806 | 72,164 | 0 |
| 30 Jun 15 | 215,709 | 2,604 | 71,082 | 0 |
| 31 Mar 15 | 210,672 | 2,084 | 69,697 | 0 |
| 31 Dec 14 | 212,749 | 4,371 | 69,331 | 0 |
| 30 Sep 14 | 209,713 | 5,779 | 67,090 | 0 |
| 30 Jun 14 | 206,204 | 5,738 | 65,306 | 0 |
| 31 Mar 14 | 204,779 | 6,618 | 63,754 | 0 |
| 31 Dec 13 | 198,492 | 5,757 | 61,121 | 0 |
Kwaliteitswinsten: 8281 has high quality earnings.
Groeiende winstmarge: 8281's current net profit margins (1.4%) are lower than last year (1.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 8281's earnings have grown significantly by 42.4% per year over the past 5 years.
Versnelling van de groei: 8281's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 8281 had negative earnings growth (-19.4%) over the past year, making it difficult to compare to the Specialty Retail industry average (4.6%).
Rendement op eigen vermogen
Hoge ROE: 8281's Return on Equity (2.8%) is considered low.